Maven Securities LTD Acquires 60,000 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Maven Securities LTD increased its stake in Alignment Healthcare by 120% in the fourth quarter, buying 60,000 more shares and bringing its total to 110,000 shares valued at about $2.17 million.
• Alignment Healthcare continues to attract major institutional interest, with hedge funds such as Wellington Management and Invesco also boosting positions; institutions now own 86.19% of the stock.
• The company recently reported stronger-than-expected quarterly results, posting $0.05 EPS on revenue of $1.24 billion, while analysts currently rate the stock a Moderate Buy with a consensus price target of $24.30.

Maven Securities LTD grew its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 120.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 110,000 shares of the company's stock after buying an additional 60,000 shares during the quarter. Maven Securities LTD owned 0.05% of Alignment Healthcare worth $2,172,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of ALHC. Wellington Management Group LLP lifted its position in shares of Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company's stock worth $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Invesco Ltd. lifted its position in shares of Alignment Healthcare by 122.3% during the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock worth $58,387,000 after buying an additional 2,294,739 shares in the last quarter. Capital World Investors bought a new position in shares of Alignment Healthcare during the 4th quarter worth approximately $44,203,000. Loomis Sayles & Co. L P bought a new position in shares of Alignment Healthcare during the 4th quarter worth approximately $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Alignment Healthcare during the 4th quarter worth approximately $39,500,000. Institutional investors own 86.19% of the company's stock.

Insider Buying and Selling

In related news, insider Christopher J. Joyce sold 18,013 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $17.79, for a total value of $320,451.27. Following the sale, the insider owned 305,451 shares of the company's stock, valued at approximately $5,433,973.29. The trade was a 5.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Mark D. Kent purchased 14,848 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was bought at an average cost of $13.31 per share, for a total transaction of $197,626.88. Following the acquisition, the insider directly owned 14,848 shares in the company, valued at $197,626.88. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 1,554,685 shares of company stock worth $29,876,743 in the last three months. Insiders own 5.20% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. UBS Group lifted their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a "neutral" rating in a research report on Friday, May 1st. Weiss Ratings raised shares of Alignment Healthcare from a "sell (d-)" rating to a "hold (c-)" rating in a research report on Thursday, May 7th. KeyCorp reissued an "overweight" rating on shares of Alignment Healthcare in a research report on Wednesday. Zacks Research raised shares of Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, April 28th. Finally, Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $24.30.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $19.75 on Monday. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The stock has a market capitalization of $4.08 billion, a PE ratio of 219.44, a price-to-earnings-growth ratio of 2.67 and a beta of 1.14. The firm's 50 day moving average is $18.53 and its 200 day moving average is $19.41. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. Alignment Healthcare's revenue was up 33.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.05) EPS. Sell-side analysts expect that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.